A Cluster Randomised Trial Comparing the Impact of Immediate Versus WHO Recommendations Guided ART Initiation on HIV Incidence. The ARNS 12249 TasP (Treatment as Prevention) Trial in Hlabisa Sub-district, KwaZulu-Natal, South Africa.
Latest Information Update: 07 Nov 2021
Price :
$35 *
At a glance
- Drugs Efavirenz/emtricitabine/tenofovir-disoproxil-fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 18 Dec 2018 Results published in the JAIDS
- 26 Jul 2017 Results assessing virological response and emergence of drug resistance, presented at the 9th International AIDS Society Conference on HIV Science.
- 26 Jul 2017 Results of care trajectories and factor associated (n=787) presented at the 9th International AIDS Society Conference on HIV Science